Inventor · disambiguated record
Mitsuro Kanda
Also filed as: KANDA Mitsuro
3 granted patents·2 pending applications·0 citations·filing 2016–2023
50Inventor score
Files withNATIONAL UNIV CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM2YMMUNOBIO AG2UNIV NAGOYA NAT UNIV CORP1
Top patents by PatentIndex Score
5 records- 0172US12129301B2Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugsNATIONAL UNIV CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM·Filed 2022·Granted Oct 29, 2024·0 cites·6 claims
- 0272US12098205B2Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugsYMMUNOBIO AG·Filed 2023·Granted Sep 24, 2024·0 cites·7 claims
- 0356US11773169B2Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugsYMMUNOBIO AG·Filed 2019·Granted Oct 3, 2023·0 cites·6 claims
- 0448US2022282248A1Molecular targeted nucleic acid medicine for gastric cancerNATIONAL UNIV CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM·Filed 2020·Application pending·0 cites
- 0527US2019024179A1Method for testing peritoneal dissemination of gastric cancer by expression level of syt13, syt8, or anos1, test kit, method for screening molecularly targeted therapeutic agent, and therapeutic agentUNIV NAGOYA NAT UNIV CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mitsuro Kanda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →